Altimmune, Inc. (ALT)
2.855
-0.06
(-2.23%)
USD |
NASDAQ |
May 15, 16:00
2.86
0.00 (0.00%)
After-Hours: 20:00
Altimmune Market Cap : 555.22M for May 15, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Eli Lilly & Co. | 896.13B |
| Madrigal Pharmaceuticals, Inc. | 12.07B |
| Amgen, Inc. | 176.21B |
| Verastem, Inc. | 379.61M |
| Karyopharm Therapeutics, Inc. | 173.82M |
Market Cap Related Metrics
| PS Ratio | 7850.67 |
| Price to Book Value | 1.955 |
| Price | 2.855 |
| Earnings Yield | -32.84% |